ICON plc
(NASDAQ : ICLR)

( )
ICLR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -0.98%237.602.7%$120.81m
ARGXargenx SE -1.34%377.490.0%$86.87m
VRXValeant Pharmaceuticals International, Inc. -3.37%5.7414.1%$33.77m
RVMDRevolution Medicines, Inc. -4.75%23.050.0%$29.26m
ENVBEnveric Biosciences, Inc. 10.85%7.460.0%$6.43m
USNAUSANA Health Sciences, Inc. 0.76%72.744.2%$4.44m
ANIKAnika Therapeutics, Inc. 1.71%23.259.7%$1.72m
CLVRClever Leaves Holdings, Inc. -2.80%0.950.0%$1.45m
BGXXBright Green Corp. -2.44%1.200.0%$0.99m
CDTXCidara Therapeutics, Inc. 0.69%0.700.7%$0.62m
CDXCChromadex Corp. -0.61%1.632.7%$0.58m
FLGCFlora Growth Corp. 1.43%0.950.0%$0.57m
PMCBPharmaCyte Biotech, Inc. -0.35%2.820.0%$0.47m
IBIOiBio, Inc. -3.24%0.270.2%$0.44m
SMFLSmart for Life, Inc. 1.09%0.570.0%$0.43m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.